营养风险筛查2002和APACHE Ⅱ与老年危重患者预后的关系  

The relationship among Nutrition Risk Screening 2002,APACHE Ⅱ and the prognosis of critically ill elderly patients

作　　者：安志红[1] 王殿华[1] 张静[1] 吴晓棣 许家俊[1] 

机构地区：[1]上海市第二人民医院,上海200011

出　　处：《内科急危重症杂志》2014年第4期235-236,243,共3页Journal of Critical Care In Internal Medicine

基　　金：上海市卫生局资助项目(No:20114332)

摘　　要：目的:探讨营养风险筛查2002(NRS2002)和急性生理学与慢性健康状况评分Ⅱ(APACHEⅡ)与老年危重症患者预后的关系。方法:根据患者的预后,分为存活组和死亡组,比较2组间NRS2002值与APACHEⅡ值的差别;再根据APACHEⅡ值分为3组,比较3组NRS2002值和病死率的差别;最后以NRS2002值和APACHEⅡ值为自变量进行logistic回归分析,探讨NRS2002评分和APACHEⅡ评分与老年危重症患者预后的关系。结果:158例老年危重症患者中,48例死亡,110例存活,死亡组NRS2002值及APACHEⅡ值显著高于存活组(均P<0.01),随着APACHEⅡ值增加,NRS2002值、病死率逐渐升高,各组间比较差异有统计学意义(均P<0.05);logistic回归分析显示,NRS2002值和APACHEⅡ值与患者预后呈正相关。结论:老年危重症患者,NRS2002值与APACHEⅡ值越高预后越差。Objective：To explore the relationship between NRS2002,APACHE Ⅱ and the prognosis of critically ill elderly patients.Methods：Patients were divided into survival group and death group according to the prognosis,the NRS2002and APACHE Ⅱ scores were compared between the two groups.Then patients were then divided into 3 groups according to the APACHE Ⅱ scores,the scores of NRS2002 and mortality rate were compared among 3 groups.Logistic regression analysis were used to explore the relationship among NRS2002 and APACHE Ⅱ and the prognosis of critically ill elderly patients.Results：Of 158 patients,the NRS2002 and APACHE Ⅱ scores in the death group （48 cases） were significantly higher than those in survival group （110 cases） （P 〈 0.01）.As the score of APACHE Ⅱ increased,the scores of the NRS2002 and mortality rate increased gradually,there were differences in the NRS2002 scores and mortality rate among 3 groups （P 〈 0.05）.The scores of NRS2002 and APACHE Ⅱ was positively correlated with the prognosis of the patients according to the logistic regression analysis,and there was differences between 3 groups （P 〈 0.05）.Conclusion：As the increase of the scores of NRS2002 and APACHE Ⅱ,the prognosis of the critically ill elderly patients is poor.

关 键 词：APACHEⅡ 营养风险筛查2002 危重症 老年患者 预后 

分 类 号：R591[医药卫生—内科学]